# A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects

> **NCT06670898** · PHASE1 · COMPLETED · sponsor: **Nippon Shinyaku Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** [14C] NS-580

## Key facts

- **NCT ID:** NCT06670898
- **Lead sponsor:** Nippon Shinyaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-08
- **Primary completion:** 2024-01-18
- **Final completion:** 2024-01-18
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06670898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06670898, "A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06670898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*